Press Releases
Search
-
15 Apr 2019
“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients
bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp announced at ECCMID (European Congress of Clinical Microbiology...
-
02 Apr 2019
University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 - The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicine...
-
19 Mar 2019
Partnerships
Baxter et bioMérieux annoncent leur collaboration pour améliorer l'identification et le traitement de l’insuffisance rénale aiguë
Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the g...
-
27 Feb 2019
bioMérieux – 2018 Financial Results
Organic sales growth of 9.9% for full-year 2018: €2,421 million in sales Up 5.8% as reported Solid fourth-quarter performance, with organic growth of more than 10% Improvement in contributive operatin...
-
07 Feb 2019
bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing
bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) d...
-
19 Dec 2018
bioMérieux receives FDA clearance for BPA and BPN culture bottles used with BACT/ALERT® VIRTUO® for quality control testing of platelets
bioMérieux, a world leader in the field of in vitro diagnostics, announces that its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (F...